Definium Therapeutics Inc

Mid-Cap Stocks Pharmaceutical Stocks Healthcare Stocks

$46.14

+0.00 (+0.00%)

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 22 96%

Hold 1 4%

Sell 0 0%

Price Target

Analyst Price Target -0.3% upside

Low Target $39.37

Average Target $46.00

High Target $57.04

Current Price $46.14

Current
$46.14

Target
$46.00

$39.37 $46.00 avg $57.04

Scenario Analysis

Bear Case

$39.37

-14.7%

Low target

Base Case

$46.00

-0.3%

Avg target

Bull Case

$57.04

+23.6%

High target

Risk/Reward

1.6x

Balanced

Price in Context

52-Week High

$49.20

-6.2% from high

52-Week Low

$8.70

+430.3% from low

Target vs 52W High

$46.00

-6.5% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	38	79%	$1,330.33	+12.2%
RDY Dr. Reddy's Laboratories	Strong Sell	45	31%	—	+0.0%
JNJ Johnson & Johnson	Buy	31	71%	$299.55	+15.5%
MRK Merck & Co. Inc.	Buy	36	69%	$159.27	+23.9%
PFE Pfizer Inc.	Hold	36	39%	$33.90	+26.7%
BMY Bristol-Myers Squibb Co	Hold	35	40%	$174.50	+169.6%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-36.1%
ZTS Zoetis Inc	Hold	24	54%	$209.87	+188.8%